<DOC>
	<DOCNO>NCT00793390</DOCNO>
	<brief_summary>Background : - Inflammatory breast cancer ( IBC ) rare , poorly understood particularly aggressive form breast cancer . - Three characteristic IBC tumor rapid progression , extensive formation new blood vessel , fact characteristic present inception tumor make ideal model study factor associate tumor aggressiveness . - This study collaboration among several institution United States North Africa extensive epidemiological experience experience IBC . Objectives : - To understand cause certain type breast condition , include IBC . Eligibility : - Women 18 year age old IBC non-IBC healthy woman volunteer eligible . Women previous diagnosis kind breast cancer exclude . Design : - Participants complete questionnaire provide information background , include medical reproductive history , family health history lifestyle habit undergo follow additional procedure : - Height , weight , hip chest measurement . - Saliva sample collection measure biological factor may relate breast condition . - Breast examination , permission give , photographs affect breast . - Analysis biopsied tissue genetic biochemical factor .</brief_summary>
	<brief_title>Case-Control Study Inflammatory Breast Cancer North Africa</brief_title>
	<detailed_description>Inflammatory breast cancer ( IBC ) rare , poorly understood particularly aggressive form breast cancer characterize diffuse erythema edema/peau orange breast . The propose case-control study risk factor IBC include approximately 400 IBC case accrue two-year period center four country North Africa ( major cancer center select private clinician Tunisia , major cancer center Egypt , 2 cancer center Algeria , 2 cancer center Morocco ) . Two control group include : 1 ) 400 non-IBC breast cancer case ; 2 ) 400 visitor control ( exclude breast , ovarian , endometrial , nasopharyngeal cancer ) study hospital . The study involve administration questionnaire , anthropometric measurement , saliva collection study subject . In addition , digital photograph breast collect IBC case , clinical examination form paraffin-embedded tumor tissue collect IBC case non-IOBC breast cancer control . The study conduct consortium , form development translation coordinate National Cancer Institute ( USA ) . A review study procedure do first three month data collection . The National Cancer Institute ( NCI ) -Division Cancer Epidemiology Genetics ( DCEG ) , NCI-Office International Affairs ( OIA ) , University Michigan , International Breast Cancer Research Foundation ( IBCRF ) provide fund project .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Inflammatory Breast Neoplasms</mesh_term>
	<criteria>The casecontrol study restrict woman least 18 year age . IBC case define clinical sign redness , either edema peau ' orange characteristic IBC evidence tumor emboli dermal lymphatics ( center Rabat ) . Cases extensive ulceration breast breast carcinoma 'en cuirasse ' exclude study , even erythema present . Women previous diagnosis breast cancer exclude . All cancer pathologically confirm evidence tumor either breast parenchyma dermal lymphatics base diagnostic biopsy . Cases newly diagnose and/or treat study hospital include .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 15, 2016</verification_date>
	<keyword>Case-Control</keyword>
	<keyword>Inflammatory Breast Cancer</keyword>
	<keyword>North Africa</keyword>
	<keyword>IBC</keyword>
</DOC>